Patents by Inventor Anja Bosserhoff

Anja Bosserhoff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROGNOSTIC AND THERAPEUTIC SIGNATURE FOR MALIGNANT MELANOMA
    Publication number: 20140094588
    Abstract: The present invention relates to a method of predicting the course of disease in a patient having a malignant melanoma, the method comprising determining in melanoma cells comprised in a sample obtained from said malignant melanoma the presence or amount of at least five biomarkers selected from the group comprising or consisting of MTAP, PTEN, Bax, Bcl-X, ?-Catenin, CD20, Cox-2, CD49d and MLH1, wherein the absence or decreased amount of MTAP and ?-Catenin and/or the presence or increased amount of PTEN, Bax, Bcl-X, CD20, Cox-2, CD49d and MLH1, is associated with a disadvantageous course of disease.
    Type: Application
    Filed: March 30, 2012
    Publication date: April 3, 2014
    Applicants: Universität Regensburg
    Inventors: Stefanie Meyer, Anja Bosserhoff, Peter Wild, Thomas Fuchs
  • NEUROENDOCRINE FACTORS FOR TREATMENT OF DEGENERATIVE DISEASES
    Publication number: 20110002972
    Abstract: The present invention is related to the use of a repellent factor and/or polypeptide for manufacturing of a pharmaceutical composition for treating a disease such as a degenerative disease in particular to the use of a SLIT3 or NETRIN1 protein therefore. The invention is further related to a polypeptide fragment of SLIT3, a pharmaceutical composition comprising the polypeptide and the use thereof.
    Type: Application
    Filed: September 12, 2008
    Publication date: January 6, 2011
    Applicant: SCIL Technology GMBH
    Inventors: Anja Bosserhoff, Thomas Schubert, Elisabeth Hustert